Human NRAGE disrupts E-cadherin/β-catenin regulated homotypic cell-cell adhesion

被引:27
作者
Xue, B [1 ]
Wen, CJ [1 ]
Shi, YH [1 ]
Zhao, DH [1 ]
Li, CJ [1 ]
机构
[1] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210097, Peoples R China
基金
中国国家自然科学基金;
关键词
NRAGE; E-cadherin; beta-catenin; cell adhesion;
D O I
10.1016/j.bbrc.2005.08.069
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human NRAGE, a neurotrophin receptor p75 interaction MAGE homologue, confers NGF-dependent apoptosis of neuronal cells by inducing caspase activation through the JNK-c-jun-dependent pathway and arrests cell growth through the p53-dependent pathway. Our findings showed that human NRAGE could significantly alter the cell skeleton and inhibit homotypic cell-cell adhesion in U2OS cells. With further experiments, we revealed that human NRAGE disrupts colocalization of the E-cadherin/beta-catenin complex and translocates beta-catenin from the cell membrane into the cytoplasm and nucleus. Synchronously, NRAGE also decreases the total protein level of beta-catenin, especially when NRAGE expresses for a long time. More importantly, knock down of NRAGE by RNA interference in PANC-1 cell significantly reinforces E-cadherin/beta-catenin homotypic cell adhesion. The data demonstrate the importance of human NRAGE in homotypic cell-to-cell adhesion and illuminate the mechanism of human NRAGE in the process of inhibition of cell adhesion, which suggests that human NRGAE plays a potential negative role in cancer metastasis. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 50 条
  • [31] The reduced expression of E-cadherin, α-catenin and γ-catenin but not β-catenin in human lung cancer
    Toyoyama, H
    Nuruki, K
    Ogawa, H
    Yanagi, M
    Matsumoto, H
    Nishijima, H
    Shimotakahara, T
    Aikou, T
    Ozawa, M
    ONCOLOGY REPORTS, 1999, 6 (01) : 81 - 85
  • [32] Ksp-cadherin is a functional cell-cell adhesion molecule related to LI-cadherin
    Wendeler, MW
    Praus, M
    Jung, R
    Hecking, M
    Metzig, C
    Gessner, R
    EXPERIMENTAL CELL RESEARCH, 2004, 294 (02) : 345 - 355
  • [33] The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions
    Bobryshev, YV
    Lord, RSA
    Watanabe, T
    Ikezawa, T
    CARDIOVASCULAR RESEARCH, 1998, 40 (01) : 191 - 205
  • [34] EXPRESSION OF CELL-ADHESION MOLECULE E-CADHERIN IN HUMAN ARACHNOID VILLI
    YAMASHIMA, T
    TOHMA, Y
    YAMASHITA, J
    JOURNAL OF NEUROSURGERY, 1992, 77 (05) : 749 - 756
  • [35] E-cadherin and β-catenin are down-regulated in prostatic bone metastases
    Bryden, AAG
    Hoyland, JA
    Freemont, AJ
    Clarke, NW
    Wismayer, DS
    George, NJR
    BJU INTERNATIONAL, 2002, 89 (04) : 400 - 403
  • [36] E-cadherin, α-catenin and β-catenin in biliary atresia:: Correlation with apoptosis and cell cycle
    Sasaki, H
    Nio, M
    Iwami, D
    Funaki, N
    Sano, N
    Ohi, R
    Sasano, H
    PATHOLOGY INTERNATIONAL, 2001, 51 (12) : 923 - 932
  • [37] The prognostic role of E-cadherin and -catenin overexpression in laryngeal squamous cell carcinoma
    Greco, Antonio
    De Virgilio, Armando
    Rizzo, Maria Ida
    Pandolfi, Fabio
    Rosati, Davide
    de Vincentiis, Marco
    LARYNGOSCOPE, 2016, 126 (04) : E148 - E155
  • [38] Immunohistochemical characterization of the expression of cell adhesion molecules E-cadherin and beta-catenin in the invasive endometrioid endometrial carcinoma
    Tumanskiy, V. A.
    Chepets, A. V.
    PATHOLOGIA, 2015, (02): : 75 - 80
  • [39] Adriamycin activates E-cadherin-mediated cell-cell adhesion in human breast cancer cells
    Yang, SZ
    Kohno, N
    Kondo, K
    Yokoyama, A
    Hamada, H
    Hiwada, K
    Miyake, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (06) : 1109 - 1115
  • [40] Immunohistochemical expression of E-cadherin and β-catenin in the normal and malignant human endometrium:: An inverse correlation between E-cadherin and nuclear β-catenin expression
    Shih, HC
    Shiozawa, T
    Miyamoto, T
    Kashima, H
    Feng, YZ
    Kurai, M
    Konishi, I
    ANTICANCER RESEARCH, 2004, 24 (06) : 3843 - 3850